Director of Galectin Therapeutics Inc (NASDAQ:GALT), 10X Fund, L.P., sells 10,000 shares worth $20,400
According to Galectin Therapeutics Inc's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 05 10:47 AM, company Director, 10X Fund, L.P. disclosed selling 10,000 shares at a cost of $2.04. At the time of this transaction (Feb 02), this trade was worth $20,400 in total. As of Feb 02, 10X Fund, L.P. now owns 6,336,440 shares in total worth about $14,510,447.6.
For the last few recent trades made by Galectin Therapeutics Inc (NASDAQ:GALT) Director, 10X Fund, L.P., we have the following information:
- SEC Form 4 filing: Oct 10: Sold 17,000 shares at the rate of $3.73 per share. Total worth of this trade was $63,325. Total number of shares owned as of Oct 10 were 6,385,790
- SEC Form 4 filing: Jun 14: Sold 76,385 shares at the rate of $8.28 per share. Total worth of this trade was $632,133. Total number of shares owned as of Jun 14 were 2,725,261
- SEC Form 4 filing: Jun 15: Sold 15,475 shares at the rate of $8.47 per share. Total worth of this trade was $131,073. Total number of shares owned as of Jun 15 were 2,709,786
Posted by
George Daniels
on Friday February 05 2021, 5:16 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
